Related Experiment Videos
Recombinant antibodies for the selective targeting of tumor neovasculature
Francesca Viti1, Leonardo Giovannoni, Dario Neri
1Swiss Federal Institute of Technology Zurich, Institute of Pharmaceutical Sciences, Winterthurerstrasse 190, CH-8057, Zurich, Switzerland.
Abstract:
Angiogenesis, the sprouting of new blood vessels from preexisting ones, is a characteristic feature of many aggressive solid tumors. Advances in the identification of markers of angiogenesis and new methodologies for the production of human recombinant antibodies are making it possible to deliver bioactive molecules to the tumor neovasculature in a selective fashion. This review illustrates how recombinant antibody derivatives may open new avenues for the imaging and therapy of angiogenesis-related diseases, such as cancer, blinding ocular disorders and rheumatoid arthritis.
Insights
Recombinant antibodies target new blood vessels in tumors and diseases like cancer. This approach offers new ways to image and treat angiogenesis-related conditions.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- Angiogenesis, the formation of new blood vessels, is crucial for aggressive solid tumors.
- Identifying angiogenesis markers and producing recombinant antibodies enables targeted delivery of molecules to tumor neovasculature.
Purpose of the Study:
- To review the potential of recombinant antibody derivatives for targeting angiogenesis.
- To explore applications in imaging and therapy for angiogenesis-related diseases.
Main Methods:
- Review of current literature on angiogenesis markers.
- Analysis of advancements in human recombinant antibody production.
- Discussion of targeted delivery strategies to tumor neovasculature.
Main Results:
- Recombinant antibody derivatives show promise for selective delivery of bioactive molecules.
- Potential applications identified for cancer, blinding ocular disorders, and rheumatoid arthritis.
Conclusions:
- Recombinant antibody technology offers novel strategies for the imaging and therapy of angiogenesis.
- Targeted approaches can improve treatment outcomes for angiogenesis-dependent diseases.